Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin plus low-dose aspirin for prevention of recurrent severe preeclampsia-related complications
2008-006489-27Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of enoxaparin in preeclampsia (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Composite clinical primary endpoint. Started May 2009; status: completed.
02
Drugs
enoxaparin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on 2008-006489-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006489-27.